News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,078 Results
Type
Article (87697)
Company Profile (824)
Press Release (777543)
Multimedia
Podcasts (184)
Webinars (28)
Section
Business (233158)
Career Advice (4142)
Deals (39827)
Drug Delivery (143)
Drug Development (91335)
Employer Resources (203)
FDA (18338)
Job Trends (17414)
News (397649)
Policy (39945)
Tag
Academia (3006)
Academic (2)
Accelerated approval (24)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (162)
Alzheimer's disease (1749)
Antibody-drug conjugate (ADC) (298)
Approvals (18423)
Artificial intelligence (569)
Autoimmune disease (123)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (182)
Biotechnology (487)
Bladder cancer (147)
Brain cancer (59)
Breast cancer (567)
Cancer (4497)
Cardiovascular disease (400)
Career advice (3564)
Career pathing (39)
CAR-T (272)
CDC (59)
Cell therapy (749)
Cervical cancer (35)
Clinical research (76281)
Collaboration (1551)
Company closure (5)
Compensation (1034)
Complete response letters (64)
COVID-19 (2973)
CRISPR (92)
C-suite (714)
Cystic fibrosis (145)
Data (5514)
Decentralized trials (2)
Denatured (67)
Depression (127)
Diabetes (487)
Diagnostics (7151)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (205)
Drug shortages (36)
Duchenne muscular dystrophy (218)
Earnings (99864)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134299)
Executive appointments (1008)
FDA (21118)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1406)
Gene editing (199)
Generative AI (57)
Gene therapy (603)
GLP-1 (1073)
Government (5414)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (269)
Immuno-oncology (30)
Indications (69)
Infectious disease (3238)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (212)
Interviews (816)
IPO (17940)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (635)
Lymphoma (325)
Machine learning (37)
Management (66)
Manufacturing (717)
MASH (164)
Medical device (14957)
Medtech (14995)
Mergers & acquisitions (22851)
Metabolic disorders (1264)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (309)
Neuropsychiatric disorders (80)
Neuroscience (2913)
NextGen: Class of 2025 (7703)
Non-profit (5100)
Now hiring (61)
Obesity (601)
Opinion (323)
Ovarian cancer (149)
Pain (181)
Pancreatic cancer (195)
Parkinson's disease (262)
Partnered (33)
Patents (457)
Patient recruitment (380)
Peanut (58)
People (66571)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23534)
Phase II (33102)
Phase III (24956)
Pipeline (3613)
Policy (316)
Postmarket research (3554)
Preclinical (10634)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (764)
Real estate (7432)
Recruiting (80)
Regulatory (28440)
Reports (65)
Research institute (2712)
Resumes & cover letters (651)
Rett syndrome (22)
RNA editing (16)
RSV (81)
Schizophrenia (145)
Series A (227)
Series B (174)
Service/supplier (30)
Sickle cell disease (90)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (45)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (115)
Vaccines (1092)
Venture capital (76)
Weight loss (422)
Women's health (73)
Worklife (21)
Date
Today (137)
Last 7 days (609)
Last 30 days (3143)
Last 365 days (33405)
2025 (31614)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (322)
Arkansas (14)
Asia (51237)
Australia (9008)
California (10616)
Canada (3115)
China (1013)
Colorado (447)
Connecticut (474)
Delaware (315)
Europe (117829)
Florida (1558)
Georgia (343)
Hawaii (3)
Idaho (68)
Illinois (880)
India (61)
Indiana (510)
Iowa (22)
Japan (362)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1387)
Massachusetts (7877)
Michigan (336)
Minnesota (615)
Mississippi (6)
Missouri (131)
Montana (34)
Nebraska (27)
Nevada (116)
New Hampshire (81)
New Jersey (2910)
New Mexico (32)
New York (2847)
North Carolina (1521)
North Dakota (10)
Northern California (4970)
Ohio (322)
Oklahoma (22)
Oregon (52)
Pennsylvania (2163)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4082)
Tennessee (164)
Texas (1660)
United States (38706)
Utah (319)
Vermont (1)
Virginia (269)
Washington D.C. (85)
Washington State (896)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
There are 866,078 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuroscience
Praxis Ends Epilepsy Study Early Due to Strong Results, Heads to FDA
Praxis has also announced a “successful” pre-NDA meeting with the FDA for its essential tremor drug candidate ulixacaltamide, for which an approval application is slated for early 2026.
December 5, 2025
·
2 min read
·
Tristan Manalac
Vaccines
CDC’s Vaccine Advisers Again Delay Hep B Vote
The ACIP decided 6–3 to postpone its vote on hepatitis B vaccination changes after the language of the questions was repeatedly changed in the days leading up to the meeting.
December 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Immatics Announces $125 Million Underwritten Offering
December 5, 2025
·
3 min read
Press Releases
Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
December 5, 2025
·
5 min read
Press Releases
Ossium Health to Present New Clinical Data on Its Organ Donor Bone Marrow at ASH 2025
December 5, 2025
·
2 min read
Press Releases
ImCheck Announces Oral Presentation of ICT01 First-Line AML Data at the 67th ASH Annual Meeting
December 5, 2025
·
4 min read
Press Releases
Vicore to Present at the Oppenheimer Movers in Rare Disease Summit
December 5, 2025
·
1 min read
Press Releases
Cantargia Provides Update on Overall Survival Data from TRIFOUR
December 5, 2025
·
5 min read
Press Releases
ORIC® Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025
December 5, 2025
·
6 min read
Press Releases
Ipsen provides update on legacy of Henri Beaufour
December 5, 2025
·
5 min read
1 of 86,608
Next
